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each protocol to detect these deviations from the treatment 
plan is investigated by comparing the planned and the 
modified PET image. Several analysis methods are used: line 
profiles coupled to the field-directions, structural similarity 
index analysis [1], and gamma index analysis. [2]  
Preliminary data shows that a difference in density is best 
detected by starting the scan directly after the first field. 
However, shifts perpendicular to the field directions are 
better detected when the scan is done after the last field, 
due to the increased activity and counting-rate. 
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Purpose: Adaptive radiotherapy aims to synchronize the 
treatment beam with the tumour motion. It requires the 
prediction of respiratory motion which has received much 
attention for over a decade. The performance of prediction 
algorithms to the dose delivery to the tumour is evaluated for 
the first time in terms of CTV-PTV margin.  
Methods and Materials: Clinical tumour volume (CTV) is 
outlined in treatment planning and is aimed to be irradiated 
with sufficient dose. Owing to uncertainties including 
respiration-induced motion, a sufficient margin around CTV is 
defined to form planning target volume (PTV). PTV is 
irradiated to ensure sufficient dose delivery to CTV, whereas 
CTV-PTV margin should be minimal to avoid irradiating 
normal tissues outside CTV. In this work, we adopt tumour 
control probability (TCP) to quantify sufficient dose delivery 
using TCP model based on Poisson statistics. The CTV-PTV 
margin required to yield 90% TCP is evaluated for no 
prediction (a baseline algorithm that refers to using the 
current measurement as a lookahead prediction.) and 
recently proposed EKF-GPRN prediction algorithm [1] at 
lookahead lengths of 192 ms, 384 ms and 576 ms. 
A large database of 304 three dimensional respiratory motion 
traces from a group of 31 patients is employed to evaluate 
algorithms. We assume that a spherical-shaped CTV with a 
radius of 2.5 mm undergoes 3-D motion along these traces. 
Algorithms are used to predict the center of CTV and the 
prediction error is considered as the deviation of treatment 
beam from the CTV.  
Results: Patient-wise statistics for CTV-PTV margin required 
to achieve 90% TCP are given for each algorithm in the 
following table. The values in the parenthesis are percent 
ratios relative to no prediction. The results show that EKF-
GPRN reduces the required CTV-PTV margin to around 20% on 
average, compared to no prediction across all the lookahead 
lengths. It indicates that EKF-GPRN can significantly improve 
dose conformality and effectively reduce normal tissue 
exposure. 
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Purpose: Tumor hypoxia is linked to poor prognosis, but 
personalized hypoxic intervention with radiosensitizers (e.g., 
nimorazole), bioreductive drugs or dose escalation to hypoxic 
tumor volumes may improve outcome. Hypoxia-selective PET 
tracers like FMISO and FAZA are available, but inherent 
weaknesses of PET in general (low resolution) and hypoxia 
PET in particular (low image contrast due to slow tracer 
retention and clearance) may compromise the quantitative 
accuracy and reproducibility of hypoxia PET. 
Methods: To assess the severity of this problem, and refine 
and optimize scan protocols to overcome them, various 
human and rodent tumors were established in mice.  
Subsequently, mice were scanned using different scan 
protocols on a high-resolution (~1 mm) Mediso nanoPET/MRI. 
Some mice were scanned dynamically for 3-hours to allow 
full pharmacokinetic analysis (PET imaging gold standard) 
followed by tumor dissection, cryosectioning and high-
resolution analysis of tracer distribution (autoradiography) 
and hypoxia (pimonidazole), on multiple tissue sections 
covering the whole tumor volume. Other mice were scanned 
statically at two different post-injection (PI) time points, to 
mimic the image contrast obtainable clinically (1.5h PI) and a 
much better contrast (3h PI), which can only be obtained in 
rodents due to rapid clearance of unbound tracer in 
organisms with high metabolic rates. On the next day, the 
same mice were scanned again at 1.5h PI or at 1.5 and 3h PI 
followed by invasive tissue analysis as described above. 
Results/Conclusions: An analysis of the distribution of FAZA 
(autoradiograms) and hypoxia (pimonidazole) on tissue 
sections revealed that 3h PI static scans, provide highly 
accurate spatial information on hypoxia, and thus serve as a 
gold standard. Despite a dramatic increase in inter-tissue and 
intra-tumoral image contrast at late scan times (3h PI), a 
voxel-by-voxel comparison revealed an excellent correlation 
between early (1.5h) and delayed (3h) scans. In addition, the 
day-to-day spatial reproducibility (overall tracer uptake and 
its spatial distribution) was good, even when scans were 
acquired at a clinical achievable contrast. Taken together, 
these results suggest that target definition is reasonable 
robust and reliable at a clinical achievable contrast. In 
contrast a simplified, and thus clinically feasible, dynamic 
model that both integrates information on blood flow/tracer 
wash-in (deduced from the FAZA signal during the first 15 
min of the scan) and tracer retention (deduced at 1.5 h PI), 
was unexpectedly less reliable, in terms of hypoxia-
specificity, than the uncorrected low-contrast static scan. 
This may relate to an uncoupling between blood flow and 
oxygen delivery capacity in the abnormal tumor vasculature. 
Whether, similar limitations apply to full dynamic scans are 
currently being investigated, using a variety of differing 
pharmacokinetic models.  
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Tracking detectors at the LHC rely on hybrid pixel detectors 
which tag each particle with an extremely high signal to 
noise ratio and with a time precision of at most 25ns. The 
same technology has been adapted to numerous other 
applications by successive Medipix Collaborations. The most 
recent imaging chip, called Medipix3, permits spectroscopic 
X-ray imaging at high spatial resolution and relatively high 
fluxes by using inter-pixel hit-by-hit processing. The 
Timepix3 chip, on the other hand, takes the opposite 
approach detecting each hit with a time precision of 1.6ns 
and sending all data off chip for analysis. Both chips have 
opened new applications in the medical field: the first for 
spectroscopic X-ray imaging and CT and the second for beam 
and dose monitoring during hadron therapy. The presentation 
will describe the detection technology and focus on some 
examples of medical applications.  
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In recent years, the combination of techniques such as PET 
(Positron Emission Tomography) and MRI (Magnetic Resonance 
Imaging) has shown a great potential to study the processes 
and progression of diseases (cancer, Alzheimer's) as well as to 
control and observe novel treatments response.  
A brain-size PET detector ring insert for an MRI system is 
being developed that, if successful, can be inserted into any 
existing MRI system to enable simultaneous PET and MRI 
images of the brain to be acquired without mutual 
interference. 
The PET insert consists of detector blocks arranged in a ring 
of 30 cm diameter. Each detector block is composed of a 
LYSO array coupled to the Philips Digital Photon Counting. 
We divided the study of the detection system in three stages. 
First, we characterized the coupling of the scintillator crystal 
with the SiPM (Silicon Photomultiplier). Next, we simulated 
the behaviour or the ring insert using Monte Carlo methods. 
Finally, we verified the simulation results with the collected 
data.  
As a result of this methodology, we obtained the I-V curves 
and the energy and time resolution of our system. Results 
show that the coupling is appropriate and that the sensibility 
of our system is adequate to move to the next study phase: 
MRI compatibility. 
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As the use of SBRT for liver tumors increases and repeated 
treatments for the same patient become more common, it is 
increasingly important to predict liver function reserve rather 
than only likelihood of radiation-induced liver disease after 
SBRT. This study aimed to develop a local and global function 
model in the liver based upon regional and organ function 
measurements to support individualized adaptive RT. 
This local and global liver function model was constructed 
with the assumption of parallel architecture in the liver, so 
that the global function of the organ was composed of the 
sum of local function of subunits similar to a previous model 
[1].  A major advance in this model is the addition of 
incorporation of functional variability of the liver across the 
patients as well as the function probability variability over 
the subunits between 0 and 1, instead of being a binary 
number of 0 or 1.  This model was fitted to 59 datasets of 
liver regional and global organ function measures from 23 
patients obtained prior to, during and 1 month after RT. The 
local function probability of a subunit was modeled by a 
previously published sigmoid function related to MRI-derived 
regional portal venous perfusion values. The global function 
was fitted to an indocyanine green retention rate at 15 min. 
Cross-validation was performed by leave-m-out tests. Fitting 
was also performed separately for the patients with 
hepatocellular carcinoma (HCC) vs all others due to likely 
differences in the liver function as well as radiation 
sensitivity. 
The fitted liver function model showed that 1) a portal 
venous perfusion value of 68.6 ml/(100g·min) yielded a local 
function probability of 0.5; 2) the local function probability 
reached 0.9 at a perfusion value of 98 ml/(100g·min); and 3) 
at an average function probability of 0.03 (corresponding 
perfusion of 38 ml/(100g·min)) or lower, the subunits did not 
contribute to the global function. Cross-validations showed 
that the model parameters were stable. Further, the same 
amount of portal venous perfusion was translated into less 
local function probability in patients with HCC than without 
HCC, reflecting the compromised local liver function by 
cirrhosis (Fig 1). 
The utility of this liver function model was explored, 
including assessing for individual regional dose response 
functions that substantially differed from the population 
average dose response and for dose re-distribution planning 
by maximizing global liver function by sparing local highly 
functional regions. This model could be a valuable tool for 
individualized treatment planning of RT. 
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Fig. 1 The local and global liver function models fitted to the 
data divided based upon the patients who had HCC vs non-
HCC tumors. Red curves represent the model fitted to all the 
data. 
 
 
